Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations

Novel efficient vaccines are needed to control tuberculosis (TB), a major cause of morbidity and mortality worldwide. Several TB vaccine candidates are currently in clinical and preclinical development. They fall into two categories, the one of candidates designed as a replacement of the Bacille Cal...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Amaya Leunda, Aline Baldo, Martine Goossens, Kris Huygen, Philippe Herman, Marta Romano
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2014-06-01
coleção:	Vaccines
Assuntos:	tuberculosis vaccine candidate clinical trial genetically modified organism risk assessment biosafety
Acesso em linha:	http://www.mdpi.com/2076-393X/2/2/463
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!